Invasive fungal disease (IFD) is the common focus in infectious disease, microbiology, clinical pharmacology, and other related fields. According to the European Organization for Research and Treatment of Cancer/Mycoses Study Group Education and Research Consortium (EORTC/MSGERC) guidelines, the definite and probable diagnosis of IFD requires the corresponding mycological examination. To further aid in the diagnosis and management of IFD, the Clinical Microbiology Society of the China Association for the Promotion of International Exchange in Healthcare, Clinical Microbiology Group of the Laboratory Medicine Society of the Chinese Medical Association, along with the Clinical Microbiology Group of the Microbiology and Immunology Society of the Chinese Medical Association, convened a group of experts to develop guidelines and gave consensus recommendations on the indications, applicable specimens, detection techniques, result interpretation, consultation and other mycological information pertaining to various types of fungal infections. These infections include but are not limited to those affecting bloodstream, lungs, central nervous system, eyes, thoracic and abdominal cavities, joints, caused by fungi such as Candida, Aspergillus, Mucor, Pneumocystis, Cryptococcus, Marneffei, Fusarium, Sedosporium, and others.

Candidiasis; Cryptococcosis; Aspergillosis; Mucormycosis; Pneumocystis infections; Practice guideline